Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

Background/AimsAdefovir dipivoxil (ADV) is a nucleotide analogue that is effective against lamivudine-resistant hepatitis B virus (HBV). The aim of this study was to determine the long-term clinical outcomes after ADV rescue therapy in decompensated patients infected with lamivudine-resistant HBV.Me...

Full description

Bibliographic Details
Main Authors: Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2014-06-01
Series:Clinical and Molecular Hepatology
Subjects:
Adefovir dipivoxil
Lamivudine-resistant
Decompensation
Hepatitis B virus
Online Access:http://e-cmh.org/upload/pdf/cmh-20-168.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-20-168.pdf

Similar Items